Month: February 2021

Flexion Therapeutics to Advance Investigational Gene Therapy FX201 into High Dose Cohort of Phase 1 Clinical Trial in Knee Osteoarthritis and Expand Low and Mid Dose Treatment Groups

First-in-human single ascending dose trial advances to high dose cohort following positive Data Monitoring Committee review of mid dose safety...

error: Content is protected !!